C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria

por Menne, Jan, Eulberg, Dirk, Beyer, Diana, Baumann, Matthias, Saudek, Frantisek, Valkusz, Zsuzsanna, Więcek, Andrzej, Haller, Hermann
Publicado 2017

Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

por Suarez-Carmona, Meggy, Williams, Anja, Schreiber, Jutta, Hohmann, Nicolas, Pruefer, Ulrike, Krauss, Jürgen, Jäger, Dirk, Frömming, Anna, Beyer, Diana, Eulberg, Dirk, Jungelius, Jarf Ulf, Baumann, Matthias, Mangasarian, Aram, Halama, Niels
Publicado 2021

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

por Steurer, Michael, Montillo, Marco, Scarfò, Lydia, Mauro, Francesca R., Andel, Johannes, Wildner, Sophie, Trentin, Livio, Janssens, Ann, Burgstaller, Sonja, Frömming, Anna, Dümmler, Thomas, Riecke, Kai, Baumann, Matthias, Beyer, Diana, Vauléon, Stéphanie, Ghia, Paolo, Foà, Robin, Caligaris-Cappio, Federico, Gobbi, Marco
Publicado 2019